Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-23

Clinical Trial Update: Resistance Training and Amino Pyridine in Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on resistance training and Amino Pyridine for Multiple Sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amino Pyridine (amino pyridine)

Snippet

Sponsor: University of Southern Denmark | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED